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Abstract
Pancreatic surgery is still associated with a relatively high morbidity and mortality compared with other
specialties. This is a result of the complex nature of the organ, the difficult access as a result of the
retroperitoneal position and the number of technically challenging anastomoses required. Nevertheless,
the past two decades have witnessed a steady improvement in morbidity and a decrease in mortality
achieved through alterations of technique (particularly relating to the pancreatic anastomoses) together
with hormonal manipulation to decrease pancreatic secretions.
Recently minimally invasive pancreatic surgery has been attempted by several centres around the world
which has stimulated considerable interest in this approach. The majority of the cases attempted have
been distal pancreatectomies, because of the more straightforward nature of the resection and the lack
of a pancreatic ductal anastomosis, but more recently reports of laparoscopic pancreaticoduodenectomy
have started to appear.
The reports of the series to date have been difficult to interpret and although the results are claimed to be
equivalent or better than those associated with a traditional approach a careful examination of the
literature and comparison with the best results previously reported does not presently support this. In the
present review we examined all the reports of pancreatic procedures performed laparoscopically and
compared the results with those previously achieved at open surgery.
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Introduction
Over the past 20 years minimally invasive (laparoscopic) surgery
has evolved to such an extent that in suitably qualified hands the
majority of general surgical procedures can be safely carried out
laparoscopically. This development has been facilitated by
advances in technology and the tenacity of surgeons throughout
the world who have invested considerable time and expertise
developing their laparoscopic skills. Despite these advances,
however, the development of laparoscopic pancreatic surgery has
been slow and in relative terms appears to lag behind develop-
ments in other organs. A number of factors are thought to con-
tribute to this apparent delay and these include the technically
demanding nature of pancreatic surgery, the difficulty in obtain-
ing an adequate and appropriate operative field for this retroperi-
toneal structure and finally but not least anxiety concerning the
potentially devastating nature of complications relating to this
unforgiving organ. Nevertheless with the success of laparoscopic
surgery in general there is a natural drive to continue to investigate
laparoscopic pancreatic surgery with the aim of identifying and
expanding the indications and defining limitations. This review
focuses on the current evidence base for increasing the use of
laparoscopic pancreatic resection but highlights aspects that must
be considered before promoting this emerging technique.
The laparoscopic era
Since minimal access surgery was introduced in 1910, laparoscopy
has been embraced and adopted by every surgical specialty. It
presented surgeons, particularly in the early phases of develop-
ment, with many technical challenges but at the same time pro-
mised enhanced recovery for patients. This enhanced recovery was
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principally achieved by decreasing the morbidity associated with
large incisions, the associated and inevitable stress response and in
addition the post-operative ileus that follows manual handling
and desiccation of the bowel.1 Laparoscopic surgery has also been
enthusiastically received by patients as a result of better cosmetic
results and considerable publicity (particularly on the internet)
surrounding ‘the exciting development’ that these procedures rep-
resent. However, in the minds of many clinicians doubt remains
particularly with respect to the newer and more complex proce-
dures. These doubts are reinforced by unconvincing and often
conflicting results that have appeared in the literature.
Initially laparoscopy was used principally as a diagnostic tool
and represented an undisputed and significant advance in this
area. It is now also established as the gold standard for a wide
range of operations in general surgery, urology and gynaecology.
Cholecystectomy previously required hospital admission for up to
a week, but can now be safely and reliably carried out laparoscopi-
cally as a day-case procedure.2–6 In addition, the cholecystectomy
model which was associated with a number of problems during its
introduction has served to facilitate the development of other
procedures and provide a framework for education and training.
This has produced an environment which allows for and ensures
that the development of surgical skills continues and is thus able
to make maximum use of the parallel improvements in technol-
ogy. A clear example of the effect that this can produce is the rapid
development of colorectal cancer surgery and the excellent initial
results with an enhanced post-operative recovery and importantly
oncological results that are equal to those from open resections.7
Role of laparoscopy in pancreatic surgery
The first open pancreatic papillectomy was performed byHalstead
in 1898 and the same year Codivilla performed a one-stage
pancreatico-duodenectomy.8,9 A two-stage pancreatico-
duodenectomy was first described 14 years later by Kausch. In the
1930s and early 1940s pancreatic surgery made significant strides
and Taylor performed a body and tail resection in 1934. In 1935
the father of pancreatic surgeryWhipple presented a case series of
80 pancreatic ampullary tumours, which included 2 two-stage
pancreatico-duodenectomies. He then described the one stage
procedure in 1941, which was subsequently described as ‘Whip-
ple’s Procedure’ by Hunt and later in the 1940s Preistley per-
formed a total pancreatectomy for pancreatic cancer. Since the
1940s although developments in operative techniques have
evolved relatively slowly, pancreatic resections are now routine in
specialist units albeit remaining a skilled procedure.
Laparoscopy was first introduced into pancreatic surgery in the
early 1990s, and to date it has mainly been used as a diagnostic and
staging tool. It gave surgeons the privilege of a window into the
abdominal cavity to assess local tumour extension and the presence
or absence of peritoneal and serosal disease before potentially
embarking on an extensive curative resection. When combined
with steerable and sensitive ultrasound probes, the laparoscope has
proved tobe invaluable in assessingmasses in thepancreas, involve-
ment of local lymph nodes, extension of the tumour to surround-
ing organs and invasion of vascular structures.10,11 It is particularly
valuable for the assessment of cystic lesions at showing internal
septae, mural nodules and solid areas within cystic pancreatic
tumours. Assessment of suspicious lesions in the liver prior to
surgerymay also be undertaken using laparoscopic ultrasound and
any abnormalities can be biopsied at the same time.12,13 Laparo-
scopic surgery has also beenused for palliative bypass operations in
patients with inoperable pancreatic cancer and in benign disease it
is used to drain pancreatic pseudocysts.14–16
The complexity of pancreatic surgery has meant that the devel-
opment of more invasive laparoscopic techniques and particularly
formal resections has been relatively slow compared with proce-
dures in many other surgical specialties. Consequently its incor-
poration into regular clinical practice is recent and indications
remain unclear as a result of the lack of a large series (particularly
prospective studies) and long-term results. A number of factors
are responsible for these delays and have conspired against the
development of an accepted laparoscopic approach and clear
guidelines in pancreatic surgery:
• It is a technically demanding surgery involving long operating
times, indirect access to retroperitoneal structures, dissection
around major blood vessels and the construction of complex
anastomoses. These factors together with the friable nature of
the pancreas are responsible for the high morbidity and fre-
quent long hospital stays associated with pancreatic procedures
particularly if associated with any complications.17
• Localizing the tumour in the pancreas usually requires tactile
feedback to assess the site and size of the tumour. This is largely
lost in laparoscopic surgery, and for this reason people have used
laparoscopic ultrasound or resorted to hand-assisted techniques
to examine the gland.
• The learning curve is lengthy and these types of procedures
require extensive experience in open pancreatic surgery com-
bined with a high level of laparoscopic skill. Considering that
pancreatic carcinoma, suitable at presentation for a potentially
curative procedure is relatively uncommon (as little as 10% of
patients are suitable for resection), a very slow progression along
an already demanding learning curve is to be expected.18,19
Despite these limitations there remains a drive towards the
development of complex procedures in laparoscopic pancreatic
surgery and the main and clear motivation is the wish to repro-
duce the benefits from laparoscopic surgery that are achieved by
other specialties, such as colorectal surgery, where laparoscopic
techniques have reduced hospital stays, improved recovery and
attained the same oncological results as open surgery.20,21
The theoretical advantages of laparoscopic pancreatic surgery
include pain reduction and improved post-operative recovery
although there are clearly also commercial pressures, particularly
to reduce hospital stays. These factors combined with increased
public healthcare expectations, frequently fuelled by the internet,
240 HPB
HPB 2010, 12, 239–243 © 2010 International Hepato-Pancreato-Biliary Association
also play a role in driving this field forward. In addition techno-
logical developments that have facilitated the performance of
advanced procedures in other fields are often directly applicable to
pancreatic surgery. These have included in particular improved
camera systems and the availability of instruments to perform
delicate anastomoses.To date the areas that have attracted themost
interest are enucleation of presumed benign or low grade neuroen-
docrine lesions and distal resections although a small number of
formal pancreaticoduodenectomies have been performed.
Distal pancreatectomy
The majority of the reported series of formal laparoscopic pan-
creatic resections have focused on distal pancreatectomy.22 This is
mainly because distal pancreatectomy, requiring no formal anas-
tomosis of the pancreatic duct, is technically less demanding com-
pared with right-sided resections and has the lowest reported
mortality and morbidity.23,24 Access to the distal pancreas or areas
to the left of the portal vein is not only less complex than the body
or head but the fact that unlike pancreaticoduodenectomy no
formal anastomosis is required to the pancreatic duct, essentially
overcomes one of the main obstacles in performing this proce-
dures.25 Another reason for the higher rate of distal pancreatic
resections in the majority of series relates to the pathology which
because of its benign or low grade nature decreases concerns
about resection margins and lymph node involvement.23
Most of the reported case series contain relatively low numbers
with the most recent and largest series in the literature from
Kooby et al. reporting on 159 resections from 2002 to 2006.26
Previous substantial series from Mabrut et al. (1995–2002: 82
patients) and Fernandez-Cruz et al. (1998–2007: 82 patients) both
had less than 100 cases.27,28 While the authors of these series agree
on the feasibility and safety of performing laparoscopic distal
pancreatectomy, the morbidity, mortality and length of hospital
stay are similar to those published for open surgery.22
In the largest series from Kooby et al. an attempt was made to
produce matching groups by extracting appropriate patients from
the open series (200 out of 508). This is a retrospective approach
and comparison was made of a selected group of patients from the
open group. Nevertheless in these groups there was no significant
difference in major complications, fistula rates, the incidence of
re-operation or need for intensive care unit admission. This prob-
ably supports the belief that morbidity in pancreas surgery results
from the surgery itself (particularly the retroperitoneal dissection
and length of the procedure) rather than the incision.26 In addi-
tion many of the ‘laparoscopic’ procedures were hand assisted
which produces a further convergence of the operative techniques,
but this is not quantified.
It also appears that indications for surgery in the published
laparoscopic series are not equivalent to those historically thought
to require open resection.An increased number of cystic lesions in
the laparoscopic group were resected compared with their open
counterpart.
Operative time is longer in the published laparoscopic series,
although this does seem to decrease with experience in the larger
series. Blood loss appears to be reduced in laparoscopic resections
but an unmatched comparison makes this difficult to quantify.26
Portal hypertension is a challenge for laparoscopic surgery, as
dissecting the splenic vessels becomes an extremely difficult pro-
cedure, which will almost inevitably result in conversion to open
surgery.
No deaths were reported in the majority of the series including
the large ones. Morbidity was quite variable with a relatively big
range in the series reported to date (0–56%).27,29,30 Pancreatic
fistula remains the main complication after laparoscopic distal
pancreatectomy (0–20%), while in the largest open resection
series open fistula rate was reported as 5–18%.23,30–35
Post-operative hospital stay is one of the main putative advan-
tages for laparoscopic surgery, but a reportedmean stay of 7.5 days
is comparable and often longer than that of open resection.22,23
Kooby et al. reported a shorter hospital stay of 5.9  3.7 days
compared with their open matched series of 9.0  6.2 days.26
Enucleation
Enucleation of pancreatic lesions is usually performed for neu-
roendocrine tumours or benign cystic tumours assuming they do
not communicate with the pancreatic duct. Bleeding tends to be
minimal, there is no reconstruction required and enucleation is
associated with a low mortality rate.36
One area which remains difficult when contemplating a laparo-
scopic enucleation is the precise localization of the tumour (or
tumours). Pre-operative assessment using all available modalities
(CT, MRI, EUS, PET and selective venous sampling) are generally
able to accurately locate single lesions but this must be confirmed
intra-operatively. If laparoscopic ultrasound is unable to locate
the lesion then conversion to an open procedure is usually
required.37
Laparoscopic enucleation has been attempted by a number of
laparoscopic surgeons with varying degrees of success. The major-
ity of published series report no mortality, which is comparable to
that of open procedures and the accepted standard for enucle-
ation.22,36 Morbidity, however, showed an alarming increase to
66.6% and 77.8% in two published series by Berends and Lihara,
respectively.38,39 Fistula remains the main complication after lap-
aroscopic enucleation at a rate of around 29% compared with
16–23% in the best open series.22,36,40,41
Pancreatico-duodenectomy
Laparoscopic pancreatico-duodenectomy remains the biggest
challenge for pancreatic surgeons and entails not only extensive
dissection around major blood vessels but also the formation of
complex and multiple anastomoses. Even when comparing open
pancreatico-duodenectomy with open distal pancreatectomy and
enucleation the mortality and morbidity rates are significantly
higher.42,43
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Considering the technical difficulties and the significant atten-
dantmorbidity andmortality with previously reported open series
it is not surprising that techniques have been developed to attempt
to limit the potential complications. One of these is the perfor-
mance of a mini-laparotomy after laparoscopic dissection to
fashion the reconstruction.16,44–46 A hand port is employed during
this phase and canbeplaced at the beginningof the operation to aid
dissection and help control any troublesome bleeding.47
Despite these advances and the reports of early series with the
complexity of the surgery the majority of pancreatic surgeons are
not yet convinced of the benefits. This is reflected in the literature
as only four of the series reviewed had five ormore cases.22 In these
series there was no improvement in hospital stay (8–28 days) and
the associated morbidity is a concern, being reported as ‘high’ by
Gagner et al. and 60% by Lu et al.48,49 These two series also have
remarkably long operating times in excess of 510 min. The results
from Palanivelu et al. who reported a series of 45 patients are more
encouraging with a morbidity rate of 26.7%, a mean operative
time of 370 min and a mean hospital stay of 10 days.50 However,
even these data must be treated with caution as the majority of
patients were ASA (American Society of Anaesthesiologist physi-
cal status classification) I or II and thus not comparable to the
general population undergoing open pancreatico-duodenectomy.
Discussion
Laparoscopic surgery is evolving rapidly within general surgery,
but laparoscopic pancreatic surgery is progressing at a measured
pace. Retrospective data are emerging from around the world
reporting varying degrees of success but at present there are no
prospective randomized control trials.
Initial data on laparoscopic distal pancreatectomy suggest that
it may confer an advantage but true comparison to open surgery
is difficult because of the lack of matched controls. Morbidity,
particularly fistula rate, in open distal pancreatic resection appears
to have a direct relationship to increasing body mass index (BMI)
and ASA grade. In the laparoscopic series reviewed, groups appear
matched for bodymass index (BMI) andASA but there is minimal
data presented on people with a high BMI or ASA grade to directly
compare these morbidity data to the general population.
If studies show that laparoscopic enucleation can at least match
the results of open surgery this remains a promising development
as it will avoid large incisions (which have additional long-term
complications as a result of adhesions and the formation of inci-
sional hernias) for what are often benign tumours. Unfortunately
at present fistula rates remain high and caution is required.
Laparoscopic pancreatico-duodenectomy is a developing tech-
nique. If the results of Palanivelu et al. can be replicated in
matched individuals then further prospective studies could be
justified although the fact that that this procedure is mainly per-
formed for malignant rather than benign disease produces addi-
tional problems. Clear resection margins are mandatory and
appropriate lymph node sampling and resection margin frozen
sections to ensure adequate and complete clearance are manda-
tory. In addition the low percentage of operable cases at the time
of initial diagnosis, often poor prognosis despite a technically
satisfactory procedure and the extensive learning curve required
to develop adequate laparoscopic skills makes the decision to
incorporate laparoscopic pancreaticoduodenectomty into clinical
practice difficult.
There will clearly be further developments in laparoscopic
surgery in general and the data from these other areas together
with accumulating data from laparoscopic pancreas surgery is
likely to continue to clarify the indications and potential advan-
tages. Inevitably the development in procedures performed for
malignant conditions will be less rapid and data more difficult to
come by as a result of the smaller numbers. In these patients
multi-centre collaboration is likely to be required particularly to
identify clear indications and confirm advantages.
Hopefully these studies will encourage a responsible approach
to these complex and difficult patients although it is interesting to
note that while laparoscopic pancreatic surgery is still in its early
stages with many unanswered questions, reports are already
appearing where it is combined with a natural orifice transluminal
endoscopic (NOTES) approach!.51
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